Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: Role of mitogen-activated protein kinases and cell cycle regulators

被引:77
作者
Faivre, E
Skildum, A
Pierson-Mullany, L
Lange, CA
机构
[1] Univ Minnesota, Ctr Canc, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Microbiol Immunol & Canc Biol Grad Program, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Ctr Canc, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA
关键词
progesterone receptor; MAP kinase; cyclin-dependent protein kinase; cyclin D1; breast cancer; cell cycle progression;
D O I
10.1016/j.steroids.2005.02.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Progesterone receptor (PR) isoforms are dual functioning steroid hormone receptors, capable of activation of target gene transcription, and rapid stimulation of membrane-initiated intracellular signaling cascades. Herein we provided a retrospective of our recent work investigating the role of progestin-activated intracellular signaling pathways on cell cycle progression in breast cancer cell models. We show that progestininduced S-phase entry and upregulation of selected target genes, including cyclin DI, are MAPK-dependent events. Further experiments conducted with mutant PRs defective in either the transcriptional response (PR-S294A) or activation of c-Src-dependent intracellular signaling to MAPKs (PR-mPro) confirmed that the proliferative response of breast cancer cells to progestins is largely dependent on the ability of PR to rapidly activate Erk 1/2 MAPKs. During progestin-stimulated cell cycle progression, elevated cdk2 levels and activity target multiple phosphorylation sites on PR. Phosphorylation of Ser400 augments PR nuclear localization and mediates increased PR transcriptional activity in the absence of hormone, while the cdk inhibitor, p27, reversed these effects. Together, our data illustrate the versatility of PR as regulatory signaling molecules that also act as sensors for multiple kinase pathways, and suggest that progestins influence changes in breast cancer cell gene expression and proliferation via integration of PR functions as both ligand-activated transcription factors and rapid initiators of intracellular signaling pathways. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:418 / 426
页数:9
相关论文
共 40 条
[1]   Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells [J].
Bamberger, AM ;
Bamberger, CM ;
Gellersen, B ;
Schulte, HM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) :6169-6174
[2]  
Bennett JD, 1996, ONCOGENE, V13, P1073
[3]  
Beral Valerie, 2003, Lancet, V362, P419, DOI 10.1016/S0140-6736(03)14065-2
[4]   Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases [J].
Boonyaratanakornkit, V ;
Scott, MP ;
Ribon, V ;
Sherman, L ;
Anderson, SM ;
Maller, JL ;
Miller, WT ;
Edwards, DP .
MOLECULAR CELL, 2001, 8 (02) :269-280
[5]   Decreased levels of the cell-cycle inhibitor p27(Kip1) protein: Prognostic implications in primary breast cancer [J].
Catzavelos, C ;
Bhatacharya, N ;
Ung, YC ;
Wilson, JA ;
Roncari, L ;
Sandhu, C ;
Shaw, P ;
Yeger, H ;
MoravaProtzner, I ;
Kapusta, L ;
Franssen, E ;
Pritchard, KI ;
Slingerland, JM .
NATURE MEDICINE, 1997, 3 (02) :227-230
[6]  
CHALBOS D, 1987, J BIOL CHEM, V262, P9923
[7]   Influence of estrogen plus progestin on breast, cancer and mammography in healthy postmenopausal women - The Women's Health Initiative Randomized trial [J].
Chlebowski, RT ;
Hendrix, SL ;
Langer, RD ;
Stefanick, ML ;
Gass, M ;
Lane, D ;
Rodabough, RJ ;
Gilligan, MA ;
Cyr, MG ;
Thomson, CA ;
Khandekar, J ;
Petrovitch, H ;
McTiernan, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (24) :3243-3253
[8]   Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter [J].
Cicatiello, L ;
Addeo, R ;
Sasso, A ;
Altucci, L ;
Petrizzi, VB ;
Borgo, R ;
Cancemi, M ;
Caporali, S ;
Caristi, S ;
Scafoglio, C ;
Teti, D ;
Bresciani, F ;
Perillo, B ;
Weisz, A .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (16) :7260-7274
[9]   Biphasic regulation of breast cancer cell growth by progesterone: Role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1) [J].
Groshong, SD ;
Owen, GI ;
Grimison, B ;
Schauer, IE ;
Todd, MC ;
Langan, TA ;
Sclafani, RA ;
Lange, CA ;
Horwitz, KB .
MOLECULAR ENDOCRINOLOGY, 1997, 11 (11) :1593-1607
[10]   Regulation of B-Myb activity by cyclin D1 [J].
Horstmann, S ;
Ferrari, S ;
Klempnauer, KH .
ONCOGENE, 2000, 19 (02) :298-306